DPP4 and diabetes mellitus: The DPP-4 inhibitors, such as Sitagliptin [39], Vildagliptin [40], Linagliptin [41], Teneligliptin [42], Anagliptin [43], Trelagliptin [44], and Omarigliptin [45] are already in use for clinical treatment of diabetes.